# A pilot study of maternal vitamin D status and its association with breast milk and infant gut metabolites

**Authors:** Alyssa S. Gutierrez, Katherine E. Chetta, Santosh Thapa, Sigmund J. Haidacher, Kathleen M. Hoch, John E. Baatz, Anthony M. Haag, Numan Oezguen, Thomas D. Horvath, Carol L. Wagner, Melinda A. Engevik

PMC · DOI: 10.14814/phy2.70774 · Physiological Reports · 2026-03-03

## TL;DR

This study explores how a mother's vitamin D levels affect the composition of breast milk and the gut metabolites in infants.

## Contribution

The study is the first to link maternal vitamin D status with specific amino acids in breast milk and infant gut metabolites.

## Key findings

- Breast milk from mothers with sufficient vitamin D had higher levels of tryptophan, phenylalanine, and tyrosine.
- Infant stool samples showed distinct metabolite profiles based on maternal vitamin D levels, including oleamide and lacto-N-triaose.

## Abstract

Human milk contains multiple bioactive components, many of which are influenced by the mother's nutritional status. To identify the impact of maternal vitamin D status on neuroactive compounds, we conducted a post hoc analysis of breast milk and matched infant stool samples from mothers categorized as sufficient or deficient for vitamin D. Neuroactive metabolites were quantified using both targeted and nontargeted liquid chromatography with tandem mass spectrometry (LC‐MS/MS). Our findings revealed that breast milk from mothers with sufficient vitamin D levels contained significantly higher concentrations of tryptophan, phenylalanine, and tyrosine compared to milk from mothers with lower vitamin D levels. No significant differences were observed in tryptamine, kynurenine, kynurenic acid, anthranilic acid, quinolinic acid, tyramine, dopamine, epinephrine, or norepinephrine between the two groups. Among SCFAs and other acids, only hexanoic acid was significantly elevated in the breast milk of mothers with sufficient vitamin D. A nontargeted metabolomics analysis of infant stool identified distinct metabolite profiles, where oleamide, vaccenic acid, lacto‐N‐triaose, and N‐acetyl‐D‐glucosamine varied according to maternal vitamin D levels, indicating that maternal nutrient status may influence the infant gut metabolome. These findings suggest that maternal vitamin D status is associated with neurotransmitter precursor levels in breast milk and a distinct metabolomic profile of infant stool.

Vitamin D status in our pilot study was associated with higher levels of certain amino acids and hexanoic acid in breast milk and metabolites in infant stool samples.

## Linked entities

- **Chemicals:** tryptophan (PubChem CID 1148), phenylalanine (PubChem CID 994), tyrosine (PubChem CID 1153), tryptamine (PubChem CID 1150), kynurenine (PubChem CID 846), kynurenic acid (PubChem CID 3845), anthranilic acid (PubChem CID 227), quinolinic acid (PubChem CID 1066), tyramine (PubChem CID 5610), dopamine (PubChem CID 681), epinephrine (PubChem CID 838), norepinephrine (PubChem CID 951), hexanoic acid (PubChem CID 8892), oleamide (PubChem CID 5283387), vaccenic acid (PubChem CID 5281127), lacto-N-triaose (PubChem CID 53477860), N-acetyl-D-glucosamine (PubChem CID 82313)

## Full-text entities

- **Genes:** AMH (anti-Mullerian hormone) [NCBI Gene 268] {aka MIF, MIS}, LALBA (lactalbumin alpha) [NCBI Gene 3906] {aka HAMLET, LYZG}
- **Diseases:** ADHD (MESH:D001289), bronchopulmonary dysplasia (MESH:D001997), IS (MESH:D000082122), wheezing (MESH:D012135), allergies (MESH:D004342), lung diseases (MESH:D008171), asthma (MESH:D001249), ASD (MESH:D000067877), weight gain (MESH:D015430), Vitamin D (MESH:D014808), atopic diseases (MESH:D006969)
- **Chemicals:** N-phenyl butanamide (MESH:C000630220), butyrate (MESH:D002087), amino acid (MESH:D000596), cholecalciferol (MESH:D002762), quinolones (MESH:D015363), Phenylalanine (MESH:D010649), propionate (MESH:D011422), 2-mercaptoethanol (MESH:D008623), ergocalciferol (MESH:D004872), N-acetyl-D-glucosamine (MESH:D000117), fatty acids (MESH:D005227), 1-(3-dimethylaminopropyl)-3-ethylcarbodiimide hydrochloride (MESH:C000613388), MPB (MESH:C012415), CDN (-), calcidiol (MESH:D002112), tyramine (MESH:D014439), L-DOPA (MESH:D007980), bile acids (MESH:D001647), valeric acid (MESH:C038780), 5-HIAA (MESH:D006897), hexanoic acid (MESH:C037652), melatonin (MESH:D008550), oligosaccharide (MESH:D009844), betaine (MESH:D001622), lysophospholipid (MESH:D008246), L-carnitine (MESH:D002331), indole-3-lactic acid (MESH:C024139), dopamine (MESH:D004298), calcitriol (MESH:D002117), tryptamine (MESH:C030820), acetate (MESH:D000085), EDAC (MESH:D005022), acetyl-carnitine (MESH:D000108), indole-3-acetic acid (MESH:C030737), indole-3-aldehyde (MESH:C012381), H (MESH:D006859), Tryptophan (MESH:D014364), Indole (MESH:C030374), 5-HT (MESH:D012701), anthranilic acid (MESH:C031385), N-acetylserotonin (MESH:C006389), SCFA (MESH:D005232), butyric acid (MESH:D020148), Gln (MESH:D005973), lipid (MESH:D008055), ammonium acetate (MESH:C018824), kynurenic acid (MESH:D007736), lactate (MESH:D019344), isobutyric acid (MESH:C020380), Choline (MESH:D002794), acetonitrile (MESH:C032159), epinephrine (MESH:D004837), phenyllactic acid (MESH:C017648), N-phenylacetamide (MESH:C508827), succinic acid (MESH:D019802), HFBA (MESH:C033094), Vitamin D (MESH:D014807), indoleacrylic acid (MESH:C001446), methanol (MESH:D000432), histamine (MESH:D006632)
- **Species:** Staphylococcus (genus) [taxon 1279], Bifidobacterium dentium (species) [taxon 1689], Homo sapiens (human, species) [taxon 9606], Streptococcus (genus) [taxon 1301]
- **Mutations:** H05311G, Glu/Gln

## Full text

_Full body text omitted from this summary view._ Fetch the complete paper as Markdown: https://tomesphere.com/paper/PMC12956843/full.md

## Figures

7 figures with captions in the complete paper: https://tomesphere.com/paper/PMC12956843/full.md

## References

83 references — full list in the complete paper: https://tomesphere.com/paper/PMC12956843/full.md

---
Source: https://tomesphere.com/paper/PMC12956843